{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:25:48Z","timestamp":1791901548334,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T00:00:00Z","timestamp":1259798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s10067-009-1317-6","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T16:30:35Z","timestamp":1259771435000},"page":"281-288","source":"Crossref","is-referenced-by-count":8,"title":["A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations"],"prefix":"10.1007","volume":"29","author":[{"given":"Filip","family":"Van den Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,3]]},"reference":[{"key":"1317_CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/03009740510026599","volume":"34","author":"J Braun","year":"2005","unstructured":"Braun J, Baraliakos X, Brandt J et al (2005) Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Scand J Rheumatol 34:178\u2013190","journal-title":"Scand J Rheumatol"},{"key":"1317_CR2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/ard.2006.064543","volume":"66","author":"B Vander Cruyssen","year":"2007","unstructured":"Vander Cruyssen B, Ribbens C, Boonen A et al (2007) The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis 66:1072\u20131077","journal-title":"Ann Rheum Dis"},{"key":"1317_CR3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#","volume":"41","author":"D McGonagle","year":"1998","unstructured":"McGonagle D, Gibbon W, O\u2019Connor P et al (1998) Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 41:694\u2013700","journal-title":"Arthritis Rheum"},{"key":"1317_CR4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780370709","volume":"37","author":"J Braun","year":"1994","unstructured":"Braun J, Bollow M, Eggens U et al (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondyloarthropathy patients. Arthritis Rheum 37:1039\u20131045","journal-title":"Arthritis Rheum"},{"key":"1317_CR5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/art.10934","volume":"48","author":"B Muche","year":"2003","unstructured":"Muche B, Bollow M, Fran\u00e7ois RJ et al (2003) Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 48:1374\u20131384","journal-title":"Arthritis Rheum"},{"key":"1317_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.60.4.316","volume":"60","author":"L Laloux","year":"2001","unstructured":"Laloux L, Voisin MC, Allain J et al (2001) Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 60:316\u2013321","journal-title":"Ann Rheum Dis"},{"key":"1317_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L et al (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499\u2013505","journal-title":"Arthritis Rheum"},{"key":"1317_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"M Bollow","year":"2000","unstructured":"Bollow M, Fischer T, Reisshauer H et al (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis\u2014cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59:135\u2013140","journal-title":"Ann Rheum Dis"},{"key":"1317_CR9","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","volume":"54","author":"J Braun","year":"2006","unstructured":"Braun J, Landew\u00e9 R, Hermann KG, ASSERT Study Group et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicentre, randomized, double-blind, placebo-controlled, magnetic resonance imaging study. Arthritis Rheum 54:1646\u20131652","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"1317_CR10","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.61.suppl_3.iii61","volume":"61","author":"J Braun","year":"2002","unstructured":"Braun J, Sieper J (2002) Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18\u201319 January 2002. Ann Rheum Dis 61(Suppl 3):iii61\u2013iii67","journal-title":"Ann Rheum Dis"},{"key":"1317_CR11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","volume":"52","author":"D Heijde Van der","year":"2005","unstructured":"Van der Heijde D, Dijkmans B, Geusens P, Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group et al (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 52:582\u2013591","journal-title":"Arthritis Rheum"},{"key":"1317_CR12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/ard.2002.004861","volume":"62","author":"AMJ Chorus","year":"2003","unstructured":"Chorus AMJ, Miedema HS, Boonen A et al (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62:1178\u20131184","journal-title":"Ann Rheum Dis"},{"key":"1317_CR13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10067-005-1150-5","volume":"25","author":"A Ozg\u00fcl","year":"2006","unstructured":"Ozg\u00fcl A, Peker F, Taskaynatan MA et al (2006) Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168\u2013174","journal-title":"Clin Rheumatol"},{"key":"1317_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard.60.3.199","volume":"60","author":"A Zink","year":"2001","unstructured":"Zink A, Listing J, Klindworth C, German Collaborative Arthritis Centres et al (2001) The national database of the German collaborative arthritis centres: I. Structure, aims, and patients. Ann Rheum Dis 60:199\u2013203","journal-title":"Ann Rheum Dis"},{"key":"1317_CR15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"SM Linden van der","year":"1984","unstructured":"van der Linden SM, Valkenburg HA, Cats A (1984) Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"1317_CR16","first-page":"1109","volume":"14","author":"W Mau","year":"1988","unstructured":"Mau W, Zeidler H, Mau R et al (1988) Clinical features and prognosis of patients with possible ankylosing spondylitis: results of a 10-year follow-up. J Rheumatol 14:1109\u20131114","journal-title":"J Rheumatol"},{"key":"1317_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, van der Heijde D, Khan MA et al (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63:535\u2013543","journal-title":"Ann Rheum Dis"},{"key":"1317_CR18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landewe R, van der Heijde D et al (2009) The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770\u2013776","journal-title":"Ann Rheum Dis"},{"key":"1317_CR19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R et al (2009) The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783","journal-title":"Ann Rheum Dis"},{"issue":"suppl II","key":"1317_CR20","first-page":"539","volume":"65","author":"C Ribbens","year":"2006","unstructured":"Ribbens C, Vastesaeger N, Brasseur J et al (2006) An epidemiological cross-sectional study of ankylosing spondylitis in Belgium: the ASPECT cohort. Ann Rheum Dis 65(suppl II):539","journal-title":"Ann Rheum Dis"},{"key":"1317_CR21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","volume":"65","author":"J Zochling","year":"2006","unstructured":"Zochling J, van der Heijde D, Burgos-Vargos R et al (2006) ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442\u2013454","journal-title":"Ann Rheum Dis"},{"key":"1317_CR22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/ard.2006.054098","volume":"66","author":"H Haibel","year":"2007","unstructured":"Haibel H, Brandt HC, Song IH et al (2007) No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16\u00a0week open label trial. Ann Rheum Dis 66:4\u2013421","journal-title":"Ann Rheum Dis"},{"key":"1317_CR23","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","volume":"356","author":"R Bosch Van den","year":"2000","unstructured":"Van den Bosch R, Kruithof E, De Vos M et al (2000) Crohn\u2019s disease associated with spondyloarthropathy: effect of TNF-\u03b1 blockade with infliximab on articular symptoms. Lancet 356:1821\u20131822","journal-title":"Lancet"},{"key":"1317_CR24","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/ard.2003.012450","volume":"63","author":"S Generini","year":"2004","unstructured":"Generini S, Giacomelli R, Fedi R et al (2004) Infliximab in spondyloarthropathy associated with Crohn\u2019s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. Ann Rheum Dis 63:1664\u20131669","journal-title":"Ann Rheum Dis"},{"key":"1317_CR25","unstructured":"Humira\u00ae (Adalimumab) Summary of Product Characteristics (SPC). February 2008"},{"key":"1317_CR26","unstructured":"HUMIRA\u00ae (adalimumab) Receives FDA approval for treatment of Crohn\u2019s disease [press release]. Abbott Laboratories; February 27, 2007. Available via http:\/\/www.abbott.com\/global\/url\/pressRelease\/en_US\/60.5:5\/Press_Release_0428.htm . Accessed 4 Sept 2008"},{"key":"1317_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.62.1.74","volume":"62","author":"H Marzo-Ortega","year":"2003","unstructured":"Marzo-Ortega H, McGonagle D, O\u2019Connor P et al (2003) Efficacy of etanercept for treatment of Crohn\u2019s related spondyloarthritis but not colitis. Ann Rheum Dis 62:74\u201376","journal-title":"Ann Rheum Dis"},{"key":"1317_CR28","unstructured":"Enbrel\u00ae (Etanercept) Summary of Product Characteristics (SPC). July 2008"},{"key":"1317_CR29","unstructured":"Remicade\u00ae (Infliximab) Summary of Product Characteristics (SPC). August 2008"},{"issue":"suppl II","key":"1317_CR30","first-page":"218","volume":"65","author":"S Guignard","year":"2006","unstructured":"Guignard S, Gossec L, Ruyssen-Witrand A et al (2006) Tumor necrosis factor antibodies reduce uveitis flares more than soluble tumor necrosis factor receptor in spondyloarthropathy patients. Ann Rheum Dis 65(suppl II):218","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1317-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1317-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:38Z","timestamp":1559105498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1317-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1317"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1317-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,3]]}}}